cyclosporine has been researched along with Dermatitis in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.13) | 18.7374 |
1990's | 9 (28.13) | 18.2507 |
2000's | 6 (18.75) | 29.6817 |
2010's | 14 (43.75) | 24.3611 |
2020's | 2 (6.25) | 2.80 |
Authors | Studies |
---|---|
Bajwa, J | 1 |
Du, Z; Li, N; Lu, C; Wu, D; Yuan, X; Zhang, M; Zhu, W | 1 |
Fixsen, E; Kheterpal, M; Patel, J; Selim, MA | 1 |
Cannon, A; Fontaine, J; Forsythe, P; King, S; Prélaud, P; Roberts, E; Seewald, W; Steffan, J | 1 |
Colombo, S; Noli, C | 1 |
Kim, CH; Kim, JY; Lee, AY | 1 |
Cena, T; Noli, C | 1 |
Kim, BS; Kim, GW; Kim, HS; Kim, JM; Kim, MB; Ko, HC; Park, MY | 1 |
Cafarchia, C; Iatta, R; Immediato, D; Otranto, D; Puttilli, MR | 1 |
Lentini, M; Schepis, C; Siragusa, M | 1 |
Nagano, Y; Nakajima, H; Nakajima, K; Sano, S; Takahashi, M; Takahashi, Y; Tarutani, M; Yamamoto, M | 1 |
Campbell, KL; Santoro, D | 1 |
Chen, W; Gao, X; Gu, P; Jiang, X; Zeng, X; Zhou, Y | 1 |
Koch, SN; Peterson, AL; Rendahl, A; Torres, SM | 1 |
Favrot, C; Forster, S; King, S; Messinger, L; Nuttall, T; Seewald, W; Steffan, J | 1 |
Brégégère, FM; Frušić-Zlotkin, M; Larush, L; Magdassi, S; Milner, Y; Neuman, R; Soroka, Y; Tivony, R; Verkhovsky, L | 1 |
Köstler, E; Nüsslein, H; Schönlebe, J; Unger, L; Weigel, K; Wollina, U | 1 |
Barcham, G; Huntley, JF; Machell, J; Mackellar, A; Meeusen, EN; Meikle, L; Pettit, D; Smith, D; van den Broek, A | 1 |
Aherne, CM; Baker, KP; Breathnach, RM; Jones, BR; McGeady, TA; Quinn, PJ | 1 |
Harada, D; Manabe, H; Takashima, Y; Tsukumo, Y | 1 |
Griffiths, CE; Harries, MJ; McMullen, E | 1 |
Gardiner, P | 1 |
Lauerma, AI; Maibach, HI | 1 |
Gijbels, MJ; HogenEsch, H; Offerman, E; van Bekkum, DW; van Hooft, J; Zurcher, C | 1 |
Horgan-Bell, C; Krafchik, B; Nadarajah, S; Roifman, C | 1 |
Kondo, S; Marshall, JS; McKenzie, RC; Oran, A; Paglia, D | 1 |
Hosoda, Y; Morimoto, Y; Noguchi, M; Sugibayasi, K; Tani, S | 1 |
BaMaung, NY; Clark, RF; Fey, TA; Gauvin, DM; Gunawardana, IW; Henry, CL; Kawai, M; Kopecka, H; Krause, R; Lane, BC; Liu, L; Luly, JR; Marsh, K; Miller, L; Mollison, KW; Or, YS; Pong, M; Rhoades, TA; Sheets, MP; Smith, ML; Trevillyan, JM; Tu, NP; Wagner, R; Wiedeman, PE; Xie, Q | 1 |
Bavandi, A; Becker, S; Meingassner, JG | 1 |
Peter, RU; Ruzicka, T | 1 |
Duell, EA; Elder, JT; Esmann, J; Fisher, GJ; Gupta, AK; Nickoloff, BJ; Talwar, HS; Voorhees, JJ | 1 |
4 review(s) available for cyclosporine and Dermatitis
Article | Year |
---|---|
Complementary, holistic, and integrative medicine: chamomile.
Topics: Chamomile; Colic; Conjunctivitis; Cyclosporine; Dermatitis; Dermatitis, Contact; Diarrhea; Dyspepsia; Female; Flowers; Herb-Drug Interactions; Humans; Infant; Lactation; Morning Sickness; Phytotherapy; Plant Extracts; Plant Preparations; Pregnancy; Warfarin | 2007 |
Topical FK506--clinical potential or laboratory curiosity?
Topics: Administration, Cutaneous; Administration, Oral; Animals; Cell Division; Clinical Trials as Topic; Cyclosporine; Dermatitis; Guinea Pigs; Humans; Keratinocytes; Lymphocyte Activation; Male; Skin Absorption; T-Lymphocytes; Tacrolimus | 1994 |
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Drug Design; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Skin Diseases; T-Lymphocytes; Tacrolimus | 1998 |
[Cyclosporin A in the therapy of inflammatory dermatoses].
Topics: Behcet Syndrome; Cyclosporine; Dermatitis; Dermatitis, Atopic; Humans; Lichen Planus; Photosensitivity Disorders; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Localized | 1992 |
2 trial(s) available for cyclosporine and Dermatitis
Article | Year |
---|---|
Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Drug Administration Schedule; Hypersensitivity | 2013 |
A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Dose-Response Relationship, Drug; Double-Blind Method; Food Hypersensitivity; Immunosuppressive Agents | 2012 |
26 other study(ies) available for cyclosporine and Dermatitis
Article | Year |
---|---|
Juvenile cellulitis (juvenile sterile granulomatous dermatitis and lymphadenitis) in a 9-week-old puppy treated with prednisolone-cyclosporine combination therapy.
Topics: Animals; Cellulitis; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Lymphadenitis; Prednisolone | 2022 |
Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways.
Topics: Animals; Cell Line; Cell Proliferation; Cyclosporine; Cytokines; Dermatitis; Humans; Imiquimod; Inflammation; Janus Kinase 2; Keratinocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Models, Animal; Psoriasis; Quercetin; Receptor, Notch1; Signal Transduction; Skin; STAT3 Transcription Factor; T-Lymphocytes; Transcription Factors | 2020 |
Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis; Dermatologic Agents; Female; Humans; Lichenoid Eruptions | 2019 |
Ciclosporin-responsive sterile pustular dermatitides in two dogs.
Topics: Animals; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Suppuration | 2014 |
Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
Topics: Aminoquinolines; Animals; Cyclosporine; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucosamine; Imiquimod; Immunomodulation; Mice; Mice, Inbred C57BL; Organ Size; Psoriasis; Spleen; T-Lymphocytes, Regulatory | 2015 |
Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Female; Immunosuppressive Agents; Male; Pruritus; Skin | 2015 |
Refractory sclerosing panniculitis successfully treated with cyclosporin.
Topics: Cyclosporine; Dermatitis; Dermatologic Agents; Female; Humans; Middle Aged; Scleroderma, Localized; Skin | 2016 |
The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Topics: Animals; Antifungal Agents; Cyclosporine; Dermatitis; Dermatomycoses; Dogs; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Genes, MDR; Haloperidol; Humans; Malassezia; Microbial Sensitivity Tests; Promethazine; Skin; Voriconazole | 2017 |
Erosive lichen planus on an atypical site mimicking a factitial dermatitis.
Topics: Arm; Back; Biopsy; Cyclosporine; Dermatitis; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lichen Planus; Middle Aged; Skin; Steroids; Treatment Outcome | 2010 |
Circulating level of chemerin is upregulated in psoriasis.
Topics: Adult; Chemokines; Chronic Disease; Cyclosporine; Dermatitis; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Intercellular Signaling Peptides and Proteins; Leptin; Male; Metabolic Syndrome; Psoriasis; Skin; Up-Regulation | 2010 |
Use of ciclosporin in a dog with canine juvenile sterile granulomatous dermatitis and lymphadenitis.
Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Granuloma; Lymphadenitis | 2011 |
Gsdma3 mutation causes bulge stem cell depletion and alopecia mediated by skin inflammation.
Topics: Alopecia; Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Genotype; Hair Follicle; Mice; Mice, Inbred Strains; Point Mutation; Proteins; Stem Cells | 2012 |
Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study.
Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Glucocorticoids; Male; Retrospective Studies; Urinary Tract Infections | 2012 |
Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model.
Topics: Administration, Topical; Adolescent; Adult; Cell Survival; Cyclosporine; Cytokines; Dermatitis; Dermatologic Agents; Emulsions; Female; Humans; Middle Aged; Nanoparticles; Organ Culture Techniques; Psoriasis; Skin; Young Adult | 2012 |
Interstitial granulomatous dermatitis with plaques and arthritis.
Topics: Arthritis; Biopsy, Needle; Cyclosporine; Dermatitis; Female; Follow-Up Studies; Granuloma; Humans; Immunohistochemistry; Middle Aged; Plaque, Amyloid; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
The effect of immunosuppression with cyclosporin A on the development of sheep scab.
Topics: Animals; Cyclosporine; Dermatitis; Host-Parasite Interactions; Immunosuppressive Agents; Mite Infestations; Psoroptidae; Sheep; Sheep Diseases; Time Factors | 2005 |
Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis.
Topics: Animals; Anti-Inflammatory Agents; CD4-CD8 Ratio; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Foot Dermatoses; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Subsets; Male; Prednisolone; Pruritus; Treatment Outcome | 2005 |
Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Anti-Inflammatory Agents; Cell Count; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclosporine; Cytokines; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Ear, Inner; Immunoglobulin E; Immunosuppressive Agents; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Peroxidase; Phosphodiesterase Inhibitors; Picryl Chloride; Prednisolone; Rolipram; T-Lymphocytes; Time Factors; Weight Gain | 2006 |
Pyoderma gangrenosum masquerading as dermatitis artefacta.
Topics: Adult; Breast; Cyclosporine; Dermatitis; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Pyoderma Gangrenosum | 2006 |
A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Dermatitis; Disease Models, Animal; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mutation; Rodent Diseases; Skin | 1993 |
Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
Topics: Anti-Inflammatory Agents; Child; Cyclosporine; Dermatitis; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Prednisone | 1997 |
[Pathogenesis and therapy of inflammatory dermatoses. Cyclosporin, an advance in the therapy of psoriasis].
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Humans; Inflammation; Psoriasis | 1995 |
Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation.
Topics: Animals; Cell Count; Cyclosporine; Dermatitis; Disease Models, Animal; Gene Expression; Histamine; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Male; Mast Cells; Mice; Mice, Inbred BALB C; Phenotype; Polymerase Chain Reaction; RNA, Messenger | 1997 |
Characteristics of spontaneous erythema appeared in hairless rats.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Dermatologic Agents; Dexamethasone; Disease Models, Animal; Erythema; Female; Male; Rats; Rats, Wistar | 1998 |
Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506.
Topics: Animals; Cyclosporine; Dermatitis; Diet; Dose-Response Relationship, Drug; Hair; Histamine; Leukocyte Count; Male; Rats; Rats, Inbred Strains; Skin; Tacrolimus | 1992 |
Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.
Topics: Administration, Topical; Animals; Arachidonic Acid; Arachidonic Acids; Cyclosporine; Cyclosporins; Dermatitis; Dinoprostone; Enzyme Activation; Epidermis; Hyperplasia; Interleukins; Mice; Mice, Hairless; Ornithine Decarboxylase; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Transglutaminases | 1989 |